Hims & Hers director sells 7,054 shares under trading plan

Hims & Hers Health, Inc. director and Chief Policy Officer Deborah M Autor reported selling 7,054 shares of Class A common stock on December 17, 2025 at $36.71 per share.

Rhea-AI Filing Summary

Hims & Hers Health, Inc. director and Chief Policy Officer Deborah M Autor reported selling 7,054 shares of Class A common stock on December 17, 2025 at $36.71 per share. The transaction was filed on Form 4 as a sale of non-derivative securities.

After this sale, she beneficially owned 6,175 shares of Class A common stock, held directly. The filing notes that the sale was effected under a Rule 10b5-1 trading plan adopted on August 11, 2025, indicating the trades followed a pre-established plan.

Insider Trade Summary

Net Seller: 7,054 shares

Net Sell 1 txn

Insider Autor Deborah M.

Role Chief Policy Officer

Sold 7,054 shs ($259K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	7,054	$36.71	$259K

Holdings After Transaction: Class A Common Stock — 6,175 shares (Direct)

Footnotes (1)

1. F1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 11, 2025 by the Reporting Person.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider stock sale did Hims & Hers Health (HIMS) disclose in this Form 4?

The filing reports that Deborah M Autor, a director and Chief Policy Officer of Hims & Hers Health, Inc., sold 7,054 shares of Class A common stock on December 17, 2025 at $36.71 per share.

Who is the reporting person in the Hims & Hers Health (HIMS) Form 4 filing?

The reporting person is Deborah M Autor, who is identified as a Director and Chief Policy Officer of Hims & Hers Health, Inc. The Form 4 is filed by one reporting person.

How many Hims & Hers Health (HIMS) shares does the insider own after the reported sale?

Following the reported transaction, Deborah M Autor beneficially owned 6,175 shares of Hims & Hers Health, Inc. Class A common stock, held in direct ownership.

Was the Hims & Hers Health (HIMS) insider sale made under a Rule 10b5-1 trading plan?

Yes. The filing explains that the sales were effected pursuant to a Rule 10b5-1 trading plan adopted on August 11, 2025 by the reporting person.

What is the relationship of the reporting person to Hims & Hers Health (HIMS)?

The reporting person, Deborah M Autor, is listed as both a Director and an Officer of Hims & Hers Health, Inc., with the officer title of Chief Policy Officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/18/2025 - 04:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Autor Deborah M.

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Policy Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	12/17/2025		S(1)		7,054	D	$36.71	6,175	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 11, 2025 by the Reporting Person.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Deborah M Autor	12/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.